logo

For the Inventor, By the Inventor

Stoke Poges, United Kingdom

Robin Lawrence

This inventor holds 4 USPTO granted patents. Top assignee: Glaxo Laboratories Limited. Active years: 1976.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robin Lawrence. Retrieved from https://idiyas.com/inventor/robin-lawrence

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

% Patents Active = 100.0

Average Co-Inventor Count = 4.1

ph-index = 3

Forward Citations = 110(Granted Patents)


Location History:

  • Stoke Poges, EN (1976)
  • London, EN (1976)
  • London, E (1976)

Company Filing History:

goldMedal4 out of 97 
 
Glaxo Laboratories Limited
 patents

Years Active: 1976

Loading Chart...
4 patents (USPTO):Explore Patents
1. 3998829 - Steroid anaesthetics of the pregnane and 19-norpregnane series (1976-12-21),
2. 3983111 - Steroidal anaesthetics of the pregnane and 19-norpregnane series (1976-09-28),
3. 3959260 - Anaesthetic steroids of the pregnane and 19-norpregnane series having a (1976-05-25),
4. 3953429 - Anaesthetic steroids of the androstance and pregnane series (1976-04-27),

Title: The Innovations of Robin Lawrence

Introduction

Robin Lawrence is a notable inventor based in Stoke Poges, GB. He has made significant contributions to the field of anaesthetics, holding a total of three patents. His work focuses on steroidal anaesthetics, which have important applications in medical science.

Latest Patents

Lawrence's latest patents include the development of steroidal anaesthetics of the pregnane and 19-norpregnane series. These steroids are characterized by a 3.alpha.-hydroxy group, a 17.alpha.-hydrogen atom, a 20-oxo group, and at the 21-position, they feature a cyano, azido, or basic amino group. Additionally, he has described anaesthetic steroids that possess a 3.alpha.-hydroxy group, a 17.alpha.-hydrogen atom, a 20-oxo group, and at the 21-position, the residue of a sulphur nucleophile or a sulphone or sulphoxide grouping.

Career Highlights

Robin Lawrence is associated with Glaxo Laboratories Limited, where he has been able to apply his innovative ideas in a professional setting. His work has contributed to advancements in anaesthetic technology, enhancing the efficacy and safety of steroidal anaesthetics.

Collaborations

Lawrence has collaborated with notable colleagues such as Gordon H Phillipps and Christopher Earle Newall. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Robin Lawrence's contributions to the field of anaesthetics through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the medical field, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…